Skip to Content
  1. All products
  2. Weight Management
  3. Tirzepatide
  4. Weight Management
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
Tirzepatide

Tirzepatide

Lyophilized Vial · Subcutaneous Refrigerate 2–8°C · 18-month shelf life 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 133.00 $ 133.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Weight loss, blood sugar regulation, insulin sensitivity improvement, appetite reduction, fat loss while preserving lean muscle mass

Tirzepatide es un revolucionario agonista dual de los receptores GIP y GLP-1 diseñado para mejorar la pérdida de peso, regular el azúcar en sangre y mejorar la sensibilidad a la insulina. Al imitar dos hormonas incretinas clave, ayuda a reducir el apetito, retardar el vaciado gástrico y promover la pérdida de grasa mientras preserva la masa muscular magra. Tirzepatide se usa comúnmente en protocolos de optimización metabólica y recomposición corporal a largo plazo.

Clinical Indications
Type 2 DiabetesObesity / Weight LossMetabolic SyndromeInsulin ResistanceBody RecompositionCardiovascular Risk Reduction
Recommended Stacking Protocols
✓
Cagrilintide
For enhanced appetite control
✓
AOD-9604
Boosts fat metabolism
✓
5-Amino-1MQ
Supports cellular energy and metabolic rate

Mechanism of Action - Weight Management / Metabolic Pathway

Dual Receptor Agonism
Activates GIP and GLP-1 receptors simultaneously for synergistic metabolic effects no single agonist achieves.
Central Appetite Regulation
Reduces hypothalamic appetite signals producing caloric deficit without compensatory hunger.
Glucose Homeostasis
Stimulates glucose-dependent insulin secretion and suppresses glucagon.
Adipose Remodeling
Preferential visceral fat reduction with lean mass preservation.
Starting Dose
2.5mg once weekly
Initiation phase for tolerance and baseline response.
Titration
Increase by 2.5mg every 2-4 weeks as tolerated
Maintenance Range
5mg-15mg once weekly
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis inicial:2,5 mg una vez a la semana

Valoración:Aumentar en 2,5 mg cada 2-4 semanas según la tolerancia

Rango de mantenimiento típico:5 mg-15 mg una vez por semana

Period Dose Phase Clinical Notes
Starting Dose 2.5mg once weekly initiation Initial dose for treatment initiation
Titration Increase by 2.5mg every 2-4 weeks escalation Gradual increase as tolerated
Maintenance Range 5mg-15mg once weekly maintenance Typical maintenance dose range
Weeks 13–16 10.0 mg escalation Optimal efficacy window for most patients.
Week 17+ 12.5–15 mg maintenance Max studied dose. Individualize per response.
Preparation Protocol
  1. Tirzepatide se suministra como polvo liofilizado.
  2. Tirzepatide debe reconstituirse con agua bacteriostática antes de su uso.
  3. Elija el volumen de reconstitución según el tamaño del vial para facilitar la dosificación.
1
Lyophilized Powder
Tirzepatide is supplied as a lyophilized powder.
2
Reconstitution Required
Tirzepatide must be reconstituted with Bacteriostatic Water before use.
3
Choose Volume
Choose your reconstitution volume based on the vial size for easy dosing.
4
Reconstitute the Vial
Wipe stopper with alcohol swab. Inject BW slowly along the glass wall — never directly onto the powder. Allow liquid to run down the sides.
⚠️ Do not shake. Gently swirl or roll between palms (30–60 sec). Shaking causes irreversible peptide degradation.
5
Inspect & Store
Solution should be clear and colorless or slightly yellow. Discard if cloudy or particulate. Store reconstituted at 2–8°C, use within 28 days. Label with date.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 20 mg
BW: 2 mL
Concentration: 10 mg/mL
Dose Units to Draw Volume (mL) Approx. Supply
2.5 mg 25 0.25 mL 8 wks
5 mg 50 0.50 mL 4 wks
10 mg 100 1.00 mL 2 wks
15 mg 150 1.50 mL 1.3 wks
Identity
  • Name: Tirzepatide
  • Product Type: Vial | Subcutaneous Injection
  • CAS Number: 2023788-19-2
  • Available Strengths: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 45mg, 50mg, 60mg
  • Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
  • Molecular Weight: 4,813.5 Da
  • Sequence / Type: GIP/GLP-1 Dual Agonist
  • Available Strengths: 5mg, 10mg, 15mg, 20mg, 30mg, 60mg, 100mg
Quality & Purity
  • Purity: 99%+
  • Purity: ≥ 99%
  • Endotoxin: ≤ 1 EU/mg
  • Appearance: White lyophilized powder
  • Solubility: Bacteriostatic water
Storage & Handling
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Pre-use Storage: -20°C (long-term) / 2–8°C (short)
  • Post-Reconstitution: 2–8°C · Up to 28 days
  • Shelf Life: 18 months from manufacture

Timing: Use consistent administration timing for stable protocol tracking.

Storage: Refrigerate 2–8°C · 18-month shelf life

Frequency: StartingDose:2.5mgonceWeekly TypicalMaintenanceRange:5mg-15mgonceWeekly

Cycle: Titration:Increaseby2.5mgevery2-4weeksastolerated

Injection Sites: Rotate approved injection sites to reduce local irritation risk.